TABLE 1.
Source | References | Agent | Mechanism |
Biological extract | Nan et al., 2022 | Astaxanthine | Astaxanthine reduces ROS overexpression, mitochondrial dysfunction, and apoptosis via NRF2-mediated pathway. |
Paciello et al., 2020 | Curcumin | Curcumin increases the endogenous antioxidant defense system (increased Nrf-2 and HO-1 expression) and reduces inflammation and apoptosis (decreased NF-kB and p53). | |
H2 | Fransson et al., 2021 | Inhalation of gaseous H2 | Inhalation of 2% gaseous H2 have antioxidant effects, rapid distribution, and distributes systemically. |
Fransson et al., 2017 | Gaseous H2 | H2 inhalation reduces the OCT2 and the CTR1 intensity and synaptophysin immunoreactivity in the synapse area around the IHCs and OHCs. | |
Synthetic chemical | Fernandez et al., 2021 | Atorvastatin | Statins come into use in improving endothelial function and microcirculation, decreasing inflammation, and reducing oxidative stress under observation. |
He et al., 2022a | ROSI (ACSL4 inhibitor) | By using ROSI to inhibit ACSL4, the production of lipid peroxide could be inhibited. | |
Cochlear cell components | Li et al., 2022c | GSTM1, GSTT1 | Loss of Gstm1 and Gstt1 affects Nrf2 expression and leads to upregulation of phase II detoxification genes. |
Cho et al., 2022 | Alpha-Lipoic Acid | Alpha-Lipoic Acid reduces the accumulation of intracellular lipid droplets to attenuates apoptosis and ferroptosis. | |
Liu et al., 2019b | Wnt | The overexpression of Wnt signaling in SGNS leads to increased expression of TP53-induced glycolysis and apoptosis regulator (TIGAR) and decreased levels of ROS. |